Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Biomarket Trends: Molecular Diagnostics on the Move
Advances in Technology, Genetics, Genomics, and Personalized Medicine Drive Growth
- As technology advances, so does the molecular diagnostics market. New tests and new instruments to perform and automate analysis continue to expand the capabilities of companies in this segment. Furthermore, the identification and validation of novel genes and biomarkers makes it possible to develop and introduce even more tests. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.